8. Jeff Geschwind’s research connects metabolic vulnerabilities in liver tumors with high-resolution Cone Beam CT imaging used during TACE. This synergy provides unmatched procedure control, allowing selective embolization tailored to tumor biology. It reflects his commitment to precision, safety, and improved patient survival in interventional oncology. https://www.usaoncologycenters.com/about/our-doctors/